Richtig, E; Loquai, C; Forschner, A; Gutzmer, R; Hassel, JC; Utikal, JS; Haferkamp, S; Meier, F; Debus, D; Dummer, R; Von Moos, RAF; Thompson, J; Gengenbacher, L; Michie-Lin, O; Hoeller, C; Schadendorf, D.
Encorafenib plus binimetinib in patients with locally advanced, unresectable, or metastatic BRAFV600-mutant melanoma: updated data from the long-term, multicenter, multinational, prospective, noninterventional BERING(MELANOMA) study
J DTSCH DERMATOL GES. 2022; 20: 96-97.-32. Deutschen Hautkrebskongresses (ADO‐Jahrestagung), 14.–17. September 2022; Sep 14-17, 2022; Hannover, Deutschland.
[Poster]
Web of Science